Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 11, 2022
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
[ Mon, Jul 11th 2022
] - WOPRAI
Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $283 on, Jul 11th, 2022
Robert Burns of HC Wainwright & Co., Maintained "BioNTech SE" (BNTX) at Strong Buy with Decreased Target from $298 to $283 on, Jul 11th, 2022.
Robert has made no other calls on BNTX in the last 4 months.
There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $180 on, Wednesday, June 1st, 2022
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $206 on, Tuesday, May 24th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $195 on, Tuesday, May 10th, 2022
These are the ratings of the 2 analyists that currently disagree with Robert
- William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $192 on, Wednesday, July 6th, 2022
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022
